The global nootropics market is projected to accomplish extraordinary growth in the forecast period, 2023-2027, with an impressive CAGR. The market growth can be attributed to the surging demands for the drugs and pharmaceuticals that support the brain’s cognitive functions. Moreover, the rapidly increasing demand for brain boosters and smart drugs among the student population is driving the growth of the global nootropics market in the upcoming five years.
The students are inclined toward nootropics for its qualities like improving cognitive function, such as executive functions, memory, creativity, or motivation. The rising awareness about these drugs is supporting the growth of the global nootropics market in the next five years. However, the ethical issues regarding the use of nootropics drugs by healthy individuals may put some restraint over the growth of the global nootropics market in the future.
In the year, 2020 the United States Food and Drug Administration and Federal Trade Commission warned the manufacturers and market players involved in the advertisements about the probable advertisement fraud and marketing scams related to nootropics substances. The issue of substance issues is also a major concern toward the drug, although regulatory sales and prospective warnings are anticipated to support the future growth of the global nootropics market in the future five years of the forecast, until 2027.
Nootropics are the drugs, supplements, and related components that are expected to work efficiently in increasing and enhancing brain activities like cognitive thinking, executive functioning of the brain, higher memory retention, and creating senses of healthy motivation for the individuals. Patients suffering from mood swings, depression, lack of attention and focus, and sleep disorders are often prescribed nootropics for their recovery. The substance is often associated with the term “smart drugs” for their functions and effects they produce over the consumer.
The global nootropics market is segmented by type, product type, distribution channel, application channel, regional distribution, and competitional analysis. Based on type, the market is further differentiated between prescription and over-the-counter nootropics drugs. Prescription nootropics drugs are anticipated to hold the largest revenue shares of the market and assert their dominance over the market segment in the upcoming five years on account of rapidly increasing cases of depression, mood swings, anxiety, and stress.
The patients suffering from such mental health issues are able to control their symptoms, and these drugs help them to facilitate their thoughts. Also, concerning legalities and ethical issues have made it essential for the prescription to e produced to purchase the nootropics drugs, thereby supporting the growth of the global nootropics market in the next five years.
Holding the major shares of the global nootropics market are Accelerated Intelligence Inc., AlternaScript LLC, Onnit Labs, Inc., Peak Nootropics LLC, Teva Pharmaceutical Industries Ltd., Purelife bioscience Co., Ltd, SupNootropic bio co., Ltd, Cephalon, Inc., United Pharmacies (UK) Ltd., Nootrobox Inc. (HVMN), among others. Market players are actively involved in the research and technological development in the product developments. The advanced technology has made it possible for the industry to provide excellent services through nootropics drugs. Further advancement would aid the market value and brand establishment in the future five years.
Objective of the Study
- To analyze the historical growth of the market size of global nootropics market from 2017 to 2020.
- To estimate and forecast the market size of global nootropics market from 2021 to 2027 and growth rate until 2027.
- To classify and forecast global nootropics market based on type, product type, distribution channel, applications, competitional landscape, and regional distribution.
- To identify dominant region or segment in the global nootropics market.
- To identify drivers and challenges for global nootropics market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global nootropics market.
- To identify and analyze the profile of leading players operating in global nootropics market.
- To identify key sustainable strategies adopted by market players in global nootropics market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and distributors across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.
TechSci Research calculated the market size of global nootropics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience
- Manufacturers, end users, and other stakeholders
- Distributers and suppliers of products and other stakeholders
- Organizations, forums, and alliances related to nootropics
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Attribute | Details |
Base Year | 2021 |
Historical Data | 2017 – 2020 |
Estimated Year | 2022 |
Forecast Period | 2023 – 2027 |
Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | · Type · Product Type · Distribution Channel · Application |
Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country scope | United States, Mexico, Canada, China, India, Japan, South Korea, Australia, Germany, France, United Kingdom, Spain, Italy, South Africa, UAE, Saudi Arabia, Kuwait, Brazil, Argentina, Colombia |
Key companies profiled | Accelerated Intelligence Inc., AlternaScript LLC, Onnit Labs, Inc., Peak Nootropics LLC, Teva Pharmaceutical Industries Ltd., Purelife bioscience Co., Ltd, SupNootropic bio co., Ltd, Cephalon, Inc., United Pharmacies (UK) Ltd., Nootrobox Inc. (HVMN). |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |